Peachtree Bioresearch Solutions

Executive Summary

Peachtree BioResearch Solutions is a full-service clinical contract research organization (CRO) headquartered in Atlanta, Georgia, serving small to mid-size biopharma and medical device sponsors. In May 2025, the company merged with Julius Clinical, creating an integrated global CRO with enhanced capabilities, particularly in central nervous system (CNS) disorders. The combined entity offers end-to-end clinical trial services including feasibility, monitoring, data management, biostatistics, and medical writing. Peachtree's solutions-based approach and focus on CNS trials position it strongly in a high-demand therapeutic area. The merger is expected to drive scale, operational efficiencies, and expansion into new geographies, while maintaining its niche appeal to emerging biopharma companies seeking specialized, agile CRO partnerships.

Upcoming Catalysts (preview)

• Q3 2026Post-Merger Integration Milestones and Synergy Realization80% success
• Q4 2026New Strategic Partnerships or Major Contract Wins with CNS Biopharma Sponsors65% success
• Q2 2027Completion of Key CNS Clinical Trial Phases Under Peachtree Management70% success